NUVL
Price:
$123.43
Market Cap:
$9.08B
Nuvalent, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering novel therapeutic solutions for individuals battling cancer. The company's pipeline features two prominent drug candidates. One of these is NVL-520, a highly selective ROS1 inhibitor capable of penetrating the brain. This compound is specifically designed to target ROS1 fusions that possess the normal ROS1 kinase domain, and crucially, it retains activity against mutations known to confer resistance to both approved and experimental ROS1 inhibitors. NVL-520 is currently undergoing Phase I clinical evaluation. Nuvalent's second key asset is NVL-655, an ALK-selective inhibitor that also exhibits brain-penetrant p...[Read more]
Industry
Biotechnology
IPO Date
2021-07-29
Stock Exchange
NASDAQ
Ticker
NUVL
According to Nuvalent, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 16.14. This represents a change of 15.86% compared to the average of 13.93 of the last 4 quarters.
The mean historical Current Ratio of Nuvalent, Inc. over the last ten years is 17.12. The current 16.14 Current Ratio has changed 9.32% with respect to the historical average. Over the past ten years (40 quarters), NUVL's Current Ratio was at its highest in in the September 2021 quarter at 44.60. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
17.12
Median
20.96
Minimum
0.76
Maximum
33.07
Discovering the peaks and valleys of Nuvalent, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.26%
Maximum Annual Current Ratio = 33.07
Minimum Annual Increase = -27.15%
Minimum Annual Current Ratio = 0.76
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 15.27 | -27.15% |
| 2024 | 20.96 | -8.17% |
| 2023 | 22.83 | -6.96% |
| 2022 | 24.54 | -25.82% |
| 2021 | 33.07 | 1.26% |
| 2020 | 2.43 | 218.92% |
The current Current Ratio of Nuvalent, Inc. (NUVL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.69
5-year avg
23.34
10-year avg
17.12
Nuvalent, Inc.’s Current Ratio is greater than Axsome Therapeutics, Inc. (1.39), greater than Merus N.V. (7.97), greater than Cytokinetics, Incorporated (4.21), greater than Metsera, Inc. (4.25), greater than Abivax S.A. (8.75), less than CRISPR Therapeutics AG (17.96), greater than Vaxcyte, Inc. (7.49), greater than Rhythm Pharmaceuticals, Inc. (4.17), greater than Jazz Pharmaceuticals plc (2.04), greater than Arrowhead Pharmaceuticals, Inc. (6.23),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.39 | $12.89B | |
| 7.97 | $6.83B | |
| 4.21 | $9.80B | |
| 4.25 | $7.43B | |
| 8.75 | $6.50B | |
| 17.96 | $5.22B | |
| 7.49 | $7.43B | |
| 4.17 | $6.64B | |
| 2.04 | $14.11B | |
| 6.23 | $11.52B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvalent, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nuvalent, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Nuvalent, Inc.'s Current Ratio?
How is the Current Ratio calculated for Nuvalent, Inc. (NUVL)?
What is the highest Current Ratio for Nuvalent, Inc. (NUVL)?
What is the 3-year average Current Ratio for Nuvalent, Inc. (NUVL)?
What is the 5-year average Current Ratio for Nuvalent, Inc. (NUVL)?
How does the current Current Ratio for Nuvalent, Inc. (NUVL) compare to its historical average?